Astrana Health (NASDAQ:ASTH) Sets New 12-Month Low - Here's What Happened

Shares of Astrana Health, Inc. (NASDAQ:ASTH - Get Free Report) reached a new 52-week low during trading on Saturday . The company traded as low as $22.58 and last traded at $22.65, with a volume of 448794 shares traded. The stock had previously closed at $24.69.

Analyst Upgrades and Downgrades

Separately, Barclays assumed coverage on shares of Astrana Health in a research note on Tuesday, April 1st. They set an "equal weight" rating and a $36.00 price objective for the company. Three analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $53.29.

Astrana Health Price Performance

The company has a debt-to-equity ratio of 0.54, a current ratio of 1.70 and a quick ratio of 1.70. The company has a market capitalization of $1.27 billion, a PE ratio of 31.46, a price-to-earnings-growth ratio of 0.83 and a beta of 0.84. The stock's 50 day simple moving average is $25.24 and its 200-day simple moving average is $30.14.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its earnings results on Thursday, May 8th. The company reported $0.14 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by ($0.09). The firm had revenue of $620.39 million for the quarter, compared to analysts' expectations of $628.11 million. Astrana Health had a return on equity of 4.90% and a net margin of 1.56%. The firm's quarterly revenue was up 53.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.31 earnings per share. As a group, equities analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Astrana Health

Several large investors have recently modified their holdings of the company. Vanguard Group Inc. lifted its holdings in shares of Astrana Health by 4.5% during the first quarter. Vanguard Group Inc. now owns 4,898,992 shares of the company's stock worth $151,918,000 after purchasing an additional 213,033 shares during the period. 325 Capital LLC lifted its holdings in Astrana Health by 30.3% in the fourth quarter. 325 Capital LLC now owns 886,916 shares of the company's stock valued at $27,964,000 after acquiring an additional 206,009 shares during the period. Hotchkis & Wiley Capital Management LLC acquired a new stake in Astrana Health in the first quarter valued at $5,564,000. Jacobs Levy Equity Management Inc. lifted its holdings in Astrana Health by 211.6% in the first quarter. Jacobs Levy Equity Management Inc. now owns 237,926 shares of the company's stock valued at $7,378,000 after acquiring an additional 161,580 shares during the period. Finally, Renaissance Technologies LLC lifted its holdings in Astrana Health by 217.6% in the fourth quarter. Renaissance Technologies LLC now owns 217,900 shares of the company's stock valued at $6,870,000 after acquiring an additional 149,300 shares during the period. 52.77% of the stock is owned by institutional investors and hedge funds.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.